Advertisement

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Welcome and Introduction to Vi3C

Opportunities to Optimize Cancer Policies Panel Discussion

Opening Session Panel Discussion

Deborah Collyar: What's In It for Patients?

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Advertisement

Advertisement

Oct

15

Today In Oncology

Study Supports Universal Germline Genetic Testing Regardless of Age at Cancer Diagnosis

Amyloidosis: Novel Treatments Could Improve Poor Outcomes

ASCO and WHO Formalize Partnership

FDA Approves Atezolizumab in Combination With Chemotherapy for Stage III dMMR Colon Cancer

Short-Course SBRT Better Preserves Physical Function Before Pancreatic Cancer Surgery

Advertisement

© 2026 HSP News Service, L.L.C.